Current guidelines recommend that people with endometriosis use hormone therapies such as a combined oral contraceptive pill (COCP) or progestogens to manage pain associated with the condition. Now, new research published in The BMJ suggests that progestogen might be a better choice than COCPs for people seeking to minimize pain as well as lower their need for future surgeries.
